IMSAInternational Medical Sciences Academy

JIMSA › Vol 18 No 2 · April–June 2005

Article · pages 104

Management of Multidrug Resistant Tuberculosis (MDR-TB)

DDS Kulpati

Cite this article

DDS Kulpati. Management of Multidrug Resistant Tuberculosis (MDR-TB). J Int Med Sci Acad. 2005;18(2):104.

Opening of the article

Tuberculosis has been a scourge of the mankind from times immemorial and is still an important health problem. The developments in pharmaco therapy and health programmes indicated the tuberculosis could be contained and probably eradicated. But the present day reality is a stunning contradiction to optimism of the earlier days tuberculosis seems to have struck back with a vengeance. Today, mutli drug resitante tuberculosis (MDR-TB) is a dreadful reality and advancing its march to destroy the national programmes to control tuberculosis. Current prevalence of primary and acquired multidrug resistance in India is 3.4% and 13.3% respectively.

Published April–June 2005 · Free to read